Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8212571 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 22 Pages |
Abstract
LTAD and RT is superior to STAD and RT for the treatment of locally advanced nonmetastatic adenocarcinoma of the prostate and should be considered the standard of care.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Colleen A.F. MD, Xiaolei MS, Gerald E. MD, Herbert MD, David J. MD, Harmar D. MD, Meena MD, Seth A. MD, Kenneth L. MD, Varagur M. MD, Eric M. MD, Thomas M. MD, Harold MD, Matthew B. MD, Rachel MD, Mack MD, Young MD, James J. PhD, Howard M. MD,